John J. Alam
CIK: 0001197014
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CervoMed Inc.
Discretionary Trading P&L
Holdings
Transaction History (10 total)
- Jun 8, 2026CRVO
CervoMed Inc.
Award(A)IndirectStock Option (Right to Buy)
8.2K shares- - Feb 11, 2026CRVO
CervoMed Inc.
Award(A)DirectStock Option (Right to Buy)
75K shares- - Nov 17, 2025CRVO
CervoMed Inc.
Purchase(P)Indirect10.8K shares at avg. $8.46$91K - Nov 17, 2025CRVO
CervoMed Inc.
Purchase(P)Direct10.8K shares at avg. $8.46$91K - Nov 14, 2025CRVO
CervoMed Inc.
Purchase(P)Direct1.7K shares at avg. $7.55$13K - Nov 14, 2025CRVO
CervoMed Inc.
Purchase(P)Indirect1.7K shares at avg. $7.57$13K - Nov 13, 2025CRVO
CervoMed Inc.
Purchase(P)Direct4.4K shares at avg. $7.51$33K - Nov 12, 2025CRVO
CervoMed Inc.
Purchase(P)Direct5.6K shares at avg. $7.35$41K - Jun 23, 2025CRVO
CervoMed Inc.
Award(A)IndirectStock Option (Right to Buy)
8.1K shares- - Feb 4, 2025CRVO
CervoMed Inc.
Award(A)DirectStock Option (Right to Buy)
60K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 8, 2026 | CRVO CervoMed Inc. | Award(A) Stock Option (Right to Buy) | 8,150 | - | - | Indirect |
| Feb 11, 2026 | CRVO CervoMed Inc. | Award(A) Stock Option (Right to Buy) | 75,000 | - | - | Direct |
| Nov 17, 2025 | CRVO CervoMed Inc. | Purchase(P) | 10,793 | $8.46 | $91,309 | Indirect |
| Nov 17, 2025 | CRVO CervoMed Inc. | Purchase(P) | 10,807 | $8.46 | $91,427 | Direct |
| Nov 14, 2025 | CRVO CervoMed Inc. | Purchase(P) | 1,693 | $7.55 | $12,782 | Direct |
| Nov 14, 2025 | CRVO CervoMed Inc. | Purchase(P) | 1,707 | $7.57 | $12,922 | Indirect |
| Nov 13, 2025 | CRVO CervoMed Inc. | Purchase(P) | 4,447 | $7.51 | $33,397 | Direct |
| Nov 12, 2025 | CRVO CervoMed Inc. | Purchase(P) | 5,553 | $7.35 | $40,815 | Direct |
| Jun 23, 2025 | CRVO CervoMed Inc. | Award(A) Stock Option (Right to Buy) | 8,100 | - | - | Indirect |
| Feb 4, 2025 | CRVO CervoMed Inc. | Award(A) Stock Option (Right to Buy) | 60,000 | - | - | Direct |
1-10 of 10 transactions
About ALAM JOHN J
ALAM JOHN J (SEC CIK 0001197014) files insider reports with the SEC as CEO & President of CervoMed Inc. (CRVO).
Signal8 holds 7 ownership filings by ALAM JOHN J, all Form 4s, filed between Feb 14, 2025 and Jun 10, 2026. Those filings report 10 transactions, from Feb 4, 2025 to Jun 8, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on ALAM JOHN J's filings is in BOSTON, MA.
Recent filings by ALAM JOHN J
- Jun 8, 2026: Grant or award of CRVO derivative securities (Form 4, code A).
- Feb 11, 2026: Grant or award of CRVO derivative securities (Form 4, code A).
- Nov 17, 2025: Open-market purchases of CRVO shares (2 lines, Form 4, code P).
- Nov 14, 2025: Open-market purchases of CRVO shares (2 lines, Form 4, code P).
- Nov 13, 2025: Open-market purchase of CRVO shares (Form 4, code P).
Other insiders filing for CervoMed Inc. (CRVO)
- Blackburn Kelly, EVP, Clinical Development
- De Rosch Mark, EVP, RA and GA and PgM
- Winton Matthew, Chief Commercial and Business
- BOGER JOSHUA S, Director
- ZAVRL FRANK, Director
- Sabbagh Marwan, Director